These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17581441)

  • 61. First trimester in utero exposure to methylphenidate.
    Dideriksen D; Pottegård A; Hallas J; Aagaard L; Damkier P
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):73-6. PubMed ID: 23136875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comment on the European guidelines for use of delayed action drugs for treatment of hyperkinetic disorders].
    Banaschewski T; Döpfner M; Rothenberger A; Steinhausen H-
    Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):77-9. PubMed ID: 18622937
    [No Abstract]   [Full Text] [Related]  

  • 63. Beyond "real boys" and back to parental obligations.
    Hughes J
    Am J Bioeth; 2005; 5(3):61-2; discussion W10-2. PubMed ID: 16006373
    [No Abstract]   [Full Text] [Related]  

  • 64. Immediate-Release Methylphenidate-Associated Recurrent Nasal Bleeding in Siblings.
    Chandradasa M; Rathnayake LC
    J Clin Psychopharmacol; 2019; 39(3):284-285. PubMed ID: 30932948
    [No Abstract]   [Full Text] [Related]  

  • 65. Beyond creativity: ADHD drug therapy as a moral damper on a child's future success.
    Krautkramer CJ
    Am J Bioeth; 2005; 5(3):52-3. PubMed ID: 16006377
    [No Abstract]   [Full Text] [Related]  

  • 66. Nasal Bleeding Probably Associated with Methylphenidate.
    Avcil S
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):924-925. PubMed ID: 29131668
    [No Abstract]   [Full Text] [Related]  

  • 67. Methylphenidate and continuous spike and wave during sleep in a child with attention deficit hyperactivity disorder.
    Sheen VL; Shankar M; Marin-Valencia I; Bridgemohan CH; Torres AR
    Pediatr Neurol; 2013 Jul; 49(1):54-7. PubMed ID: 23827428
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reversible ischaemic neurological deficit associated with short-term methylphenidate medication.
    Leonhard C; Reif A; Beck M; Jacob C; Lesch KP
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):129-30. PubMed ID: 16004621
    [No Abstract]   [Full Text] [Related]  

  • 69. 'Real' ethics for 'real' boys: context and narrative in bioethics.
    Hoffmaster B
    Am J Bioeth; 2005; 5(3):50-1; discussion W10-2. PubMed ID: 16006351
    [No Abstract]   [Full Text] [Related]  

  • 70. Is There an Effect of Methylphenidate on Thrombocytopenia?
    Ercan ES; Inci SB; Ipci M
    J Clin Psychopharmacol; 2017 Jun; 37(3):374. PubMed ID: 28301399
    [No Abstract]   [Full Text] [Related]  

  • 71. OROS-Methylphenidate-Induced Raynaud's Phenomenon: A Dose-Related Side Effect.
    Bayram Ö; Hergüner S
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):521-2. PubMed ID: 26222712
    [No Abstract]   [Full Text] [Related]  

  • 72. Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review.
    Martínez-Aguayo JC; Arancibia M; Meza-Concha N; Bustamante C; Pérez-Bracchiglione J; Madrid E
    Medwave; 2017 Jun; 17(5):e6980. PubMed ID: 28665917
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Punding Under Methylphenidate Treatment in a Patient With Adult Attention-Deficit/Hyperactivity Disorder.
    Aydin Ö; Tanriöver E; Poyraz CA
    J Clin Psychopharmacol; 2020; 40(6):631-632. PubMed ID: 33136926
    [No Abstract]   [Full Text] [Related]  

  • 74. Chemical leukoderma after the application of a transdermal methylphenidate patch.
    Ghasri P; Gattu S; Saedi N; Ganesan AK
    J Am Acad Dermatol; 2012 Jun; 66(6):e237-8. PubMed ID: 22583724
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.
    Pagerols M; Richarte V; Sánchez-Mora C; Garcia-Martínez I; Corrales M; Corominas M; Cormand B; Casas M; Ribasés M; Ramos-Quiroga JA
    Pharmacogenomics J; 2017 Jan; 17(1):98-104. PubMed ID: 26810137
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Methylphenidate in adults with attention-deficit/hyperactivity disorder].
    Kösters M; Weinmann S; Becker T
    Nervenarzt; 2007 Sep; 78(9):1065-6; author reply 1066-8. PubMed ID: 17724574
    [No Abstract]   [Full Text] [Related]  

  • 77. Excessive Masturbation Successfully Treated With Methylphenidate in a 6-Year-Old Child With Autism Spectrum Disorder Accompanied by Attention Deficit Hyperactivity Disorder.
    Ferahkaya H; Bilgiç A
    Clin Neuropharmacol; 2021 May-Jun 01; 44(3):104-105. PubMed ID: 33587487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pica in a child with attention deficit hyperactivity disorder and successful treatment with methylphenidate.
    Hergüner S; Hergüner AS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1155-6. PubMed ID: 20547198
    [No Abstract]   [Full Text] [Related]  

  • 79. Methylphenidate toxicity after Roux-en-Y gastric bypass.
    Ludvigsson M; Haenni A
    Surg Obes Relat Dis; 2016 Jun; 12(5):e55-e57. PubMed ID: 27317601
    [No Abstract]   [Full Text] [Related]  

  • 80. Excessive and Frequent Menstrual Bleeding With Methylphenidate in an Adolescent Girl With Attention-Deficit Hyperactivity Disorder.
    Coskun M; Adak I
    J Clin Psychopharmacol; 2017 Oct; 37(5):637-639. PubMed ID: 28719424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.